TABLE 2

Baseline characteristics of people with type 2 diabetes of the Casale Monferrato Study, by living status on 31 December 2006

SurvivedDeceasedP
n1,885496
Men922 (48.9)262 (52.8)0.12
Age (years)65.9 ± 10.274.1 ± 8.5<0.0001
Duration of diabetes (years)10.2 ± 7.812.6 ± 8.4<0.0001
CRP (mg/dl)2.5 (1.2–5.3)3.7 (1.6–9.1)<0.0001
    <1.6642 (34.1)117 (23.6)<0.0001
    1.6–4.4671 (35.6)163 (32.8)
    >4.4572 (30.3)216 (43.6)
BMI (kg/m2)28.9 ± 5.028.0 ± 5.40.0009
Waist circumference (cm)98.2 ± 12.298.3 ± 12.80.82
Systolic blood pressure (mmHg)145.5 ± 16.2146.7 ± 17.10.14
Diastolic blood pressure (mmHg)83.0 ± 8.282.3 ± 8.40.10
Hypertension1,653 (87.9)458 (92.3)0.005
Glucose (mg/dl)171.5 ± 53.5178.3 ± 60.00.014
A1C (%)7.0 ± 1.77.3 ± 1.90.0003
Total cholesterol (mg/dl)213.1 ± 40.0206.3 ± 40.20.001
LDL cholesterol (mg/dl)129.0 ± 34.2122.3 ± 33.90.0002
HDL cholesterol (mg/dl)54.7 ± 14.855.0 ± 16.60.70
Triglycerides (mg/dl)129.6 (92–177)127.7 (87–175)0.57
ApoA1 (mg/dl)154.9 ± 38.8150.7 ± 39.10.03
ApoB (mg/dl)102.8 ± 26.3100.0 ± 28.30.04
ApoB/apoA10.72 ± 0.330.72 ± 0.340.99
Creatinine (mg/dl)0.83 (0.69–0.97)0.93 (0.73–1.11)<0.001
Fibrinogen (g/l)372.1 ± 68.5406.9 ± 110.4<0.0001
Uric acid (mg/dl)5.52 ± 1.736.04 ± 2.51<0.0001
AER (μg/min)12.1 (4.2–25.5)21.3 (6.4–49.3)<0.0001
    20–200377 (24.3)113 (35.3)
    >20073 (4.7)28 (8.8)
CVD353 (18.7)157 (31.6)0.0001
Smoking
    Former smoker534 (29.3)166 (34.9)0.03
    Smoker291 (16.0)60 (12.6)
Glucose-lowering treatment
    Diet303 (71.0)62 (12.7)<0.0001
    Oral drugs1,402 (75.4)337 (68.9)
    Insulin155 (8.3)90 (18.4)
Statins379 (20.1)98 (19.8)0.98
  • Data are means ± SD, n (%), or geometric means (95% CI).